Platelet-to-Lymphocyte Ratio Predicts the Presence of Diabetic Neurogenic Bladder

References

• Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047–1053. doi:10.2337/diacare.27.5.1047
   PubMed Web of Science ®Google Scholar
• Yuan Z, Tang Z, He C, Tang W. Diabetic cystopathy: a review. J Diabetes. 2015;7(4):442–447. doi:10.1111/1753-0407.12272
   PubMed Web of Science ®Google Scholar
• Peng X, Li S, An Z, Li L. [Application value of American urological association symptom index score in female patients with type 2 diabetic neurogenic bladder]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2019;50(4):566–570. Chinese
   PubMedGoogle Scholar
• Kebapci N, Yenilmez A, Efe B, Entok E, Demirustu C. Bladder dysfunction in type 2 diabetic patients. Neurourol Urodyn. 2007;26(6):814–819. doi:10.1002/nau.20422
   PubMed Web of Science ®Google Scholar
• Shiny A, Bibin YS, Shanthirani CS, et al. Association of neutrophil-lymphocyte ratio with glucose intolerance: an indicator of systemic inflammation in patients with type 2 diabetes. Diabetes Technol Ther. 2014;16(8):524–530. doi:10.1089/dia.2013.0264
   PubMed Web of Science ®Google Scholar
• Horne B, Anderson J, John J, et al. Which white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol. 2005;45(10):1638–1643. doi:10.1016/j.jacc.2005.02.054
   PubMed Web of Science ®Google Scholar
• Esser N, Legrand-Poels S, Piette J, Scheen AJ, Paquot N. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract. 2014;105(2):141–150. doi:10.1016/j.diabres.2014.04.006
   PubMed Web of Science ®Google Scholar
• Vozarova B, Weyer C, Lindsay R, Pratley R, Bogardus C, Tataranni P. High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes. Diabetes. 2002;51(2):455–461. doi:10.2337/diabetes.51.2.455
   PubMed Web of Science ®Google Scholar
• Azab B, Shah N, Akerman M, McGinn J. Value of platelet/lymphocyte ratio as a predictor of all-cause mortality after non-ST-elevation myocardial infarction. J Thromb Thrombolysis. 2012;34(3):326–334. doi:10.1007/s11239-012-0718-6
   PubMed Web of Science ®Google Scholar
• Liu J, Du J, Fan J, et al. The neutrophil-to-lymphocyte ratio correlates with age in patients with papillary thyroid carcinoma. ORL J Otorhinolaryngol Relat Spec. 2015;77(2):109–116. doi:10.1159/000375534
   Web of Science ®Google Scholar
• Semeniuk-Wojtaś A, Lubas A, Stec R, Syryło T, Niemczyk S, Szczylik C. Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and C-reactive protein as new and simple prognostic factors in patients with metastatic renal cell cancer treated with tyrosine kinase inhibitors: a systemic review and meta-analysis. Clin Genitourin Cancer. 2018;16(3):e685–e693. doi:10.1016/j.clgc.2018.01.010
   PubMed Web of Science ®Google Scholar
• Akbas E, Demirtas L, Ozcicek A, et al. Association of epicardial adipose tissue, neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio with diabetic nephropathy. Int J Clin Exp Med. 2014;7(7):1794–1801.
   PubMed Web of Science ®Google Scholar
• Mineoka Y, Ishii M, Hashimoto Y, Yamashita A, Nakamura N, Fukui M. Platelet to lymphocyte ratio correlates with diabetic foot risk and foot ulcer in patients with type 2 diabetes. Endocr J. 2019;66(10):905–913. doi:10.1507/endocrj.EJ18-0477
   PubMed Web of Science ®Google Scholar
• Wang J, Chen Z, Yang K, et al. Association between neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and diabetic retinopathy among diabetic patients without a related family history. Diabetol Metab Syndr. 2020;12:55. doi:10.1186/s13098-020-00562-y
   PubMed Web of Science ®Google Scholar
• Wang C, Kuo H. Urothelial dysfunction and chronic inflammation in diabetic patients with overactive bladder. Low Urin Tract Symptoms. 2017;9(3):151–156. doi:10.1111/luts.12126
   PubMed Web of Science ®Google Scholar
• Alberti K, Zimmet P. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539–553. doi:10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
   PubMed Web of Science ®Google Scholar
• Sakakibara R, Takahashi O, Nishimura H, et al. The relationship between bladder, periarterial and somatic neuropathy in diabetes. Intern Med Adv Publ. 2018;57(15):2165–2168. doi:10.2169/internalmedicine.9749-17
   Google Scholar
• Bouillanne O, Morineau G, Dupont C, et al. Geriatric nutritional risk index: a new index for evaluating at-risk elderly medical patients. Am J Clin Nutr. 2005;82(4):777–783. doi:10.1093/ajcn/82.4.777
   PubMed Web of Science ®Google Scholar
• Kaplan S, Blaivas J. Diabetic cystopathy. J Diabet Complications. 1988;2(3):133–139. doi:10.1016/S0891-6632(88)80024-2
   Google Scholar
• Frimodt-Møller C. Diabetic cystopathy: epidemiology and related disorders. Ann Intern Med. 1980;92:318–321. doi:10.7326/0003-4819-92-2-318
   PubMed Web of Science ®Google Scholar
• Akash MSH, Rehman K, Chen S. Role of inflammatory mechanisms in pathogenesis of type 2 diabetes mellitus. J Cell Biochem. 2013;114(3):525–531. doi:10.1002/jcb.24402
   PubMed Web of Science ®Google Scholar
• Apfel S. Neurotrophic factors and diabetic peripheral neuropathy. Eur Neurol. 1999;41(Suppl. 1):27–34. doi:10.1159/000052077
   Web of Science ®Google Scholar
• Inouye B, Hughes F, Jin H, et al. Diabetic bladder dysfunction is associated with bladder inflammation triggered through hyperglycemia, not polyuria. Res Rep Urol. 2018;10:219–225. doi:10.2147/RRU.S177633
   Web of Science ®Google Scholar
• Akash M, Shen Q, Rehman K, Chen S. Interleukin-1 receptor antagonist: a new therapy for type 2 diabetes mellitus. J Pharm Sci. 2012;101(5):1647–1658. doi:10.1002/jps.23057
   PubMed Web of Science ®Google Scholar
• Hayden M, Sowers J. Isletopathy in type 2 diabetes mellitus: implications of islet RAS, islet fibrosis, islet amyloid, remodeling, and oxidative stress. Antioxid Redox Signal. 2007;9(7):891–910. doi:10.1089/ars.2007.1610
   PubMed Web of Science ®Google Scholar
• Yang W, Wang X, Zhang W, et al. Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio are 2 new inflammatory markers associated with pulmonary involvement and disease activity in patients with dermatomyositis. Clin Chim Acta. 2017;465:11–16. doi:10.1016/j.cca.2016.12.007
   PubMed Web of Science ®Google Scholar
• Yue S, Zhang J, Wu J, Teng W, Liu L, Chen L. Use of the monocyte-to-lymphocyte ratio to predict diabetic retinopathy. Int J Environ Res Public Health. 2015;12(8):10009–10019. doi:10.3390/ijerph120810009
   PubMed Web of Science ®Google Scholar
• Hudzik B, Szkodzinski J, Gorol J, et al. Platelet-to-lymphocyte ratio is a marker of poor prognosis in patients with diabetes mellitus and ST-elevation myocardial infarction. Biomark Med. 2015;9(3):199–207. doi:10.2217/bmm.14.100
   PubMed Web of Science ®Google Scholar
• Zhang K, Ding S, Lyu X, Tan Q, Wang Z. Correlation between the platelet-to-lymphocyte ratio and diabetic foot ulcer in patients with type 2 diabetes mellitus. J Clin Lab Anal. 2021;35(4):e23719. doi:10.1002/jcla.23719
   Web of Science ®Google Scholar
• Alexandrakis M, Passam F, Moschandrea I, et al. Levels of serum cytokines and acute phase proteins in patients with essential and cancer-related thrombocytosis. Am J Clin Oncol. 2003;26(2):135–140. doi:10.1097/01.COC.0000017093.79897.DE
   PubMed Web of Science ®Google Scholar
• Ozcan Cetin E, Cetin M, Aras D, et al. Platelet to lymphocyte ratio as a prognostic marker of in-hospital and long-term major adverse cardiovascular events in ST-segment elevation myocardial infarction. Angiology. 2016;67(4):336–345. doi:10.1177/0003319715591751
   PubMed Web of Science ®Google Scholar
• Chen W, Chen K, Xu Z, et al. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio predict mortality in patients with diabetic foot ulcers undergoing amputations. Diabetes Metab Syndr Obes. 2021;14:821–829. doi:10.2147/DMSO.S284583
   PubMed Web of Science ®Google Scholar